logo

Apimeds Pharmaceuticals US

NYSEAM • APUS • US03771D2018

Market Closed

ORTEX Data Highlights

Generating your data highlights...

Market Cap

5.28m USD | # 11878 in US

Volume

3.7m shares | 16.05m USD

Shares Outstanding

1.51m

Free Float Shares

48.10% | 725.94k

News

APUS key data

Apimeds Pharmaceuticals US (NYSEAM: APUS) has a market capitalization of $5.28M. Last close $3.50 (as of 2026-10-20); 52-week range $1.51 to $59.70.